Paracetamol API manufacturer running a single Tarapur (Maharashtra) plant, part of the Aarti Group, diversifying into specialty chemicals via subsidiary VASPL.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 33 | 43 | 43 | 54 | 54 |
| Reserves | 68 | 193 | 191 | 263 | 257 |
| Borrowings | 60 | 77 | 122 | 54 | 46 |
| Other Liabilities | 52 | 29 | 45 | 54 | 107 |
| Total Liabilities | 213 | 343 | 401 | 425 | 464 |
| AssetsFixed Assets | 48 | 50 | 48 | 48 | 227 |
| CWIP | 1 | 43 | 156 | 174 | 6 |
| Investments | 34 | 38 | 0 | 48 | 28 |
| Other Assets | 130 | 212 | 197 | 155 | 202 |
| Total Assets | 213 | 343 | 401 | 425 | 464 |
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ActivitiesCash from Operating | 56 | 2 | 1 | -10 |
| Cash from Investing | -55 | -144 | -53 | 7 |
| Cash from Financing | -1 | 152 | 45 | 2 |
| SummaryCapital Expenditure | — | — | — | — |
| Free Cash Flow | 18 | -44 | -112 | -45 |
| FCF Margin | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
VALIANTLAB · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.